Autoantibodies as Diagnostic and Predictive Markers of Vitiligo

References

• Howitz, J., Brodthagen, H., Schwartz, M. and Tomsen, K. (1977) "Prevalence of vitiligo: epidemiological survey on the Isle of Bornholm, Denmark", Arch. Dennatol. 113, 47–52.
   Google Scholar
• Majumder, P.P., Nordlund, J.J. and Nath, S.K. (1993) "Pattern of familial aggregation of vitiligo", Arch. Dennatol. 129, 994–998.
   Google Scholar
• Ortonne, J.P., Mosher, D.B. and Fitzpatrick, T.B. (1983) "Vitiligo and other hypomelanoses of hair and skin", In: Ortonne, Mosher, D.B. and Fitzpatrick, TB., eds, Topics in Dermatology (Plenum Medical Book Co., New York), pp 257–258.
   Google Scholar
• Kent, G. and Al' Abadie, M.S.K. (1996) "Psychologic effects of vitiligo: a critical incident analysis", J. Am. Acad. Dennatol. 35, 895–898.
   PubMedGoogle Scholar
• Pawelek, J., Korner, A. and Bergstrom, A. (1980) "New regulation of melanin biosynthesis and autodestruction of melanoma cells", Nature 286, 617–619.
   PubMed Web of Science ®Google Scholar
• Nordlund, J.J. and Lerner, A.B. (1982) "Vitiligo. It is important", Arch. Dennatol. 118, 5–8.
   Google Scholar
• Schallreuter, KU., Wood, J.M. and Berger, J. (1991) "Low catalase levels in the epidermis of patients with vitiligo", J. Investig. Dennatol. 97, 1081–1085.
   PubMed Web of Science ®Google Scholar
• Ochi, Y. and DeGroot, L.J. (1969) "Vitiligo in Graves' disease", Ann. Intern. Med. 71, 935–940.
   PubMed Web of Science ®Google Scholar
• Naughton, G.K., Eisinger, M. and Bystryn, J.-C. (1983) "Antibodies to normal human melanocytes in vitiligo", J. Exp. Med. 158, 246–251.
   PubMedGoogle Scholar
• Ogg, G.S., Dunbar, P.R., Romero, P., Chen, J.-L. and Cerundolo, V. (1998) "High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo", J. Exp. Med. 188, 1203–1208.
   Google Scholar
• Le Poole, LC., Das, P.K., van den Wijngaard, R.M.J.G.J., Bos, J.D. and Westerhof, W. (1993) "Review of the etiopathomechanism of vitiligo: a convergence theory", Exp. Dennatol. 2, 145–153.
   Google Scholar
• Kemp, E.H., Waterman, E.A. and Weetman, A.P. (2001) "Autoimmune aspects of vitiligo", Autoimmunity 34, 65–77.
   PubMed Web of Science ®Google Scholar
• Norris, D.A., Kissinger, R.M., Naughton, G.K. and Bystryn, J.-C. (1988) "Evidence for immunologic mechanisms in human vitiligo: patients' sera induce damage to human melanocyes in vitro by complement-mediated damage and antibody-dependent cellular cytotoxicity", J. Investig. Dennatol. 90, 783–789.
   Google Scholar
• Gilhar, A., Zelickson, B., Ulman, Y. and Etzioni, A. (1995) "In vivo destruction of melanocytes by the IgG fraction of serum from patients with vitiligo", J. Investig. Dennatol. 105, 683–686.
   PubMed Web of Science ®Google Scholar
• Fishman, P., Azizi, E., Shoenfeld, Y., Sredni, B., Yesheskel, G., Ferrone, S., Zigelman, R., Chaitchik, S., Floro, S. and Djaldetti, M. (1993) "Vitiligo autoantibodies are effective against melanoma", Cancer 72, 2365–2369.
   PubMedGoogle Scholar
• Cui, J., Harning, R., Henn, M. and Bystryn, J.-C. (1992) "Identification of pigment cell antigens defined by vitiligo antibodies", J. Investig. Dennatol. 98, 162–165.
   Google Scholar
• Cui, J., Arita, Y. and Bystryn, J.-C. (1995) "Characterisation of vitiligo antigens", Pigment Cell Res. 8, 53–59.
   PubMedGoogle Scholar
• Norris, D.A., Capin, L., Muglia, J.J., Osborn, R.L., Zerbe, GO., Bystryn, J.-C. and Tonnesen, M.G. (1988) "Enhanced susceptibility of melanocytes to different immunologic effector mechanisms in vitro: potential mechanisms for post-inflammatory hypopigmen-tation and vitiligo", Pigment Cell Res. (Suppl.) 1, 113–123.
   Google Scholar
• Naughton, G.K., Eisenger, M. and Bystryn, J.-C. (1983) "Detection of antibodies to melanocytes in vitiligo by specific immuno-precipitation", J. Investig. Dennatol. 81, 540–542.
   Google Scholar
• Harning, R., Cui, J. and Bystryn, J.-C. (1991) "Relation between the incidence and level of pigment cell antibodies and disease activity in vitiligo", J. Investig. Dennatol. 97, 1078–1080.
   Google Scholar
• Naughton, G.K., Reggiardo, M.D. and Bystryn, J.-C. (1986) "Correlation between vitiligo antibodies and extent of depigmenta-tion in vitiligo", J. Am. Acad. Dennatol. 15, 978–981.
   PubMedGoogle Scholar
• Park, Y.K., Kim, N.S., Hann, S.K. and Im, S. (1996) "Identification of autoantibody to melanocytes and characterisation of vitiligo antigen in vitiligo patients", J. Dennatol. Sci. 11, 111–120.
   Google Scholar
• Rocha, I.M., Oliveira, L.J., De Castro, L.C., De Araujo Pereira, L.I., Chaul, A., Guerra, J.G., Silvestre, M.C., Batista, K.M., Pereira, F.A., Gomide, MA. and Guillo, L.A. (2000) "Recognition of melanoma cell antigens with antibodies present from patients with vitiligo", Int. J. Dennatol. 39, 840–843.
   Google Scholar
• Yu, H.S., Kao, C.H. and Yu, C.L. (1993) "Coexistence and relationship of antikeratinocyte and antimelanocyte antibodies in patients with non-segmental-type vitiligo", J. Investig. Dennatol. 100, 823–828.
   PubMed Web of Science ®Google Scholar
• Aronson, P.J. and Hashimoto, K. (1987) "Association of IgA anti-melanoma antibodies in the sera of vitiligo patients with active disease", J. Investig. Dennatol. 88, 475.
   Web of Science ®Google Scholar
• Song, Y.H., Connor, E., Li, Y, Zorovich, B., Balducci, P. and Maclaren, N. (1994) "The role of tyrosinase in autoimmune vitiligo", Lancet 344, 1049–1052.
   PubMed Web of Science ®Google Scholar
• Baharav, E., Merimski, O., Shoenfeld, Y, Zigelman, R., Gilbrund, B. and Yecheskel, G. (1996) "Tyrosinase as an autoantigen in patients with vitiligo", Clin. Exp. Immunol. 105, 84–88.
   PubMed Web of Science ®Google Scholar
• Kemp, E.H., Gawkrodger, D.J., MacNeil, S., Watson, P.F. and Weetman, A.P. (1997) "Detection of tyrosinase autoantibodies in vitiligo patients using 355-labelled recombinant human tyrosinase in a radioimmunoassay", J. Investig. Dennatol. 109, 69–73.
   PubMed Web of Science ®Google Scholar
• Xie, Z., Chen, DL., Jiao, D. and Bystryn, J.-C. (1999) "Vitiligo antibodies are not directed to tyrosinase", Arch. Dennatol. 135, 417–422.
   Google Scholar
• Kemp, E.H., Waterman, E.A., Gawkrodger, D.J., Watson, P.F. and Weetman, A.P. (1998) "Autoantibodies to tyrosinase-related protein-1 detected in the sera of vitiligo patients using a quantitative radiobinding assay", Br. J. Dennatol. 139, 798–805.
   Google Scholar
• Kemp, E.H., Gawkrodger, D.J., Watson, P.F. and Weetman, A.P. (1997) "Immunoprecipitation of melanogenic enzyme autoantigens with vitiligo sera: evidence for cross-reactive autoantibodies to tyrosinase and tyrosinase-related protein-2 (TRP-2)", Clin. Exp. Immunol. 109, 495–500.
   PubMedGoogle Scholar
• Okamoto, T., Irie, RE, Fujii, S., Huang, S.K.S., Nizze, A.J., Morton, D.L. and Hoon, D.S.B. (1998) "Anti-tyrosinase-related protein-2 immune response in vitiligo and melanoma patientsreceiving active-specific immunotherapy", J. Investig. Dennatol. 111, 1034–1039.
   PubMed Web of Science ®Google Scholar
• Kemp, ER, Gawkrodger, D.J., Watson, RR and Weetman, AR (1998) "Autoantibodies to human melanocyte-specific protein Pmell 7 in the sera of vitiligo patients: a sensitive and quantitative radioimmunoassay (RIA)", CIM. Exp. Immunol. 114, 333–338.
   PubMedGoogle Scholar
• Waterman, E.A., Kemp, ER, Gawkrodger, D.J., Watson, RR and Weetman, AR (2002) "Autoantibodies in vitiligo are not directed to the melanocyte differentiation antigen MelanA/MART1", CIM. Exp. Immunol. 129, 527–532.
   PubMedGoogle Scholar
• Hedstrand, H., Ekwall, O., Olsson, M.J., Landgren, E., Kemp, E.H., Weetman, AR, Perheentupa, J., Husebye, E., Gustafsson, J., Betterle, C., Kampe, 0. and Rorsman, F. (2001) "The transcription factors SOX9 and SOX10 are melanocyte autoantigens related to vitiligo in autoimmune polyendocrine syndrome type 1", J. Biol. Chem. 276, 35390–35395.
   PubMedGoogle Scholar
• Kemp, ER, Waterman, E.A., Hawes, BE., O'Neill, K., Gottumukkala, R., Gawkrodger, D.J., Weetman, A.P. and Watson, RR (2002) "The melanin-concentrating hormone receptor 1, a novel target of autoantibody responses in vitiligo", J. Clin. Investig. 109, 923–930.
   PubMedGoogle Scholar